Ir directamente a la navegación principal
Ir directamente a la búsqueda
Ir directamente al contenido principal
Scholars @ UT Health San Antonio Inicio
Ayuda y preguntas frecuentes
English
Español
Inicio
Perfiles
Unidades de investigación
Producción científica
Conjuntos de datos
Buscar por experiencia, nombre o afiliación
Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial
The EMPA-KIDNEY Collaborative Group
Department of Environmental and Occupational Health
Division of Nephrology/Renal Diseases
Producción científica
:
Article
›
revisión exhaustiva
36
Citas (Scopus)
Información general
Huella
Huella
Profundice en los temas de investigación de 'Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial'. En conjunto forman una huella única.
Clasificar por
Ponderación
Alfabéticamente
Medicine and Dentistry
Nephropathy
100%
Chronic Kidney Disease
100%
Empagliflozin
100%
N Ethyl 2 [N (6 Methoxy 3 Pyridinyl) 2 Methylbenzenesulfonamido] N (3 Pyridinylmethyl)acetamide
100%
Analysis
100%
Inpatient
100%
Glomerular Filtration Rate
70%
Disease Exacerbation
40%
Patient
40%
Effect Size
20%
Renal Failure
20%
Glomerulopathy
20%
Placebo
20%
Death
20%
Cardiovascular System
10%
Proportional Hazards Model
10%
Hazard Ratio
10%
Diabetic Nephropathy
10%
Diabetes
10%
Follow up
10%
Hypertension
10%
Diabetes Mellitus
10%
Screening
10%
Creatinine
10%
Albumin
10%
End Stage Renal Disease
10%
Sodium Glucose Cotransporter 2 Inhibitor
10%
Renovascular Disease
10%
Medical Research
10%
Urinary System
10%
Pharmacology, Toxicology and Pharmaceutical Science
N Ethyl 2 [N (6 Methoxy 3 Pyridinyl) 2 Methylbenzenesulfonamido] N (3 Pyridinylmethyl)acetamide
100%
Renovascular Disease
10%